兆科眼科(06622.HK)干眼症新药上市申请获受理

阿斯达克财经
May 19, 2025

兆科眼科-B(06622.HK) 公布,国家药监局最近受理公司核心产品之一环孢素眼用凝胶的新药上市申请。透过与国家药监局就环孢素眼用凝胶进行全面沟通及新药申请前讨论,公司已接获国家药监局的书面回复,同意公司基于先前完成的第III期临床试验结果以及对该项临床试验进行的进一步数据挖掘及事后分析提交的新药申请。该药是公司于中国开发以供治疗中重度干眼症的创新环孢素凝胶。(ha/da)(港股报价延迟最少...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10